Contributor(s): Naomi Burke-Shyne, Jason Eligh, Gabriel Feltran, Kasia Malinowska, Alexander Söderholm | The potential impact of COVID-19 on economic markets is well known and widely discussed. But what about the markets we know less about, namely illicit markets? Drug markets, policymakers and people who use drugs are facing an unprecedented situation. Join this discussion - a blend of on-the-ground narratives and broader policy perspectives - to hear how we might best respond. Naomi Burke-Shyne (@NaomiSBS) is the Executive Director of Harm Reduction International. She has more than 10 years of international experience at the intersection of harm reduction, HIV and human rights. She is a member of the Strategic Advisory Group to the UN on HIV and Drug Use, a member of the Global Fund Technical Review Panel for Human Rights and Gender, and a member of the World Health Organization Guidelines Group on 'Ensuring Balance in National Policies on Controlled Substances'. Jason Eligh (@JasonE
